Adults aged 18 years or older with a diagnosis of Non-segmented Facial Vitiligo may qualify to participate. Individuals must have moderate to severe Vitiligo on their face, vitiligo in other areas of the body, is permitted. However, the areas to be treated in the study will only include the face, neck, hands, forearms, and elbows. with involvement of > 0.25 to 15% body surface area (BSA).
Participants will receive investigational topical medication (active study drug) or placebo, via a cream in conjunction with phototherapy or placebo.
Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.